Conjustar
Conjustar, a protein-conjugated medicine developer, has established a robust R&D pipeline through its independent and introduction efforts.
Conjustar is a company in health care, medical, pharmaceutical based in Asia-Pacific (APAC), founded in 2022.
Conjustar is positioned in health care, medical, pharmaceutical, a segment that rewards a clear, focused offering.
The company is recorded as being based in Asia-Pacific (APAC).
Its current recorded stage is Seed.
Its team size is recorded as c_00011_00050 employees.
Total disclosed funding stands at about $190.5M.
| Sector | Health Care, Medical, Pharmaceutical |
|---|---|
| Headquarters | Asia-Pacific (APAC) |
| Founded | 2022 |
| Employees | c_00011_00050 |
| Stage | seed |
| Total funding | $190,500,000 |
Website: conjustar.com
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account